Inhibition of heparin/antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosis
- 15 July 1993
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 71 (2) , 103-111
- https://doi.org/10.1016/0049-3848(93)90176-o
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Cofactor dependent and cofactor independent anticardiolipin antibodiesThrombosis Research, 1991
- Antiendothelial Cell Antibodies in Patients with the Antiphospholipid SyndromeAutoimmunity, 1991
- Lack of cross-reactivity between anticardiolipin antibodies and glycosaminoglycansThrombosis Research, 1990
- Risk factors for thrombosis in lupus patients.Annals of the Rheumatic Diseases, 1989
- Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.Journal of Clinical Investigation, 1986
- Polyspecificity of Monoclonal Lupus Autoantibodies Produced by Human-Human HybridomasNew England Journal of Medicine, 1983
- Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids.The Journal of Experimental Medicine, 1981
- Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH)Thrombosis Research, 1977
- HEPARIN-INDUCED DECREASE IN CIRCULATING ANTITHROMBIN-IIIThe Lancet, 1977